When was Baxter founded?

Baxter was founded in 1931 and raised its 1st funding round 81 years after it was founded.

Where is Baxter located?

Baxter is headquartered in Deerfield, United States.

How many employees does Baxter have?

As of Jan 09, 2026, the latest employee count at Baxter is 39385.

Is Baxter a funded company?

Baxter is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2012.

When was the latest funding round of Baxter?

Baxter's latest funding was a $***** Grant (prize money) round on May 19, 2022, with participation from 1 investor.

What is the annual revenue of Baxter?

Annual revenue of Baxter is $10.6B as on Dec 31, 2024.

Where does Baxter rank among its competitors?

Baxter ranks 11th amongst 1553 active competitors, of which 59 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Biorad Medisys, which secured $47.9M in May, 2024.

Who are the top competitors of Baxter?

Baxter's top competitors include Boston Scientific, Medtronic and Fujifilm. Among them, Biorad Medisys secured the most recent funding round in May, 2024.

Baxter - 2026 Company Profile, Team, Funding, Competitors & Financials

Baxter is an acquired company based in Deerfield (United States), founded in 1931. It operates as a Provides biosciences, medication delivery and renal products. Baxter has raised an undisclosed amount in funding. The company has 1553 active competitors, including 59 funded and 105 that have exited. Its top competitors include companies like Boston Scientific, Medtronic and Fujifilm.

Company Details

Baxter International develops, manufactures and markets products to treat people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. In 2023, the company recorded annual revenues of $15.05B and a net loss of $2.46B.

Website: www.baxter.com
Social
Email ID: *****@baxter.com
Phone Number: +1 **********

Key Metrics

Founded Year

1931

Location

Deerfield, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), May 19, 2022, $*****

Investors

Triodos Investment Management & 8 more

Ranked

11^th among 1553 active competitors

Annual Revenue

$10.6B as on Dec 31, 2024

Employee Count

39,385 as on Jan 09, 2026

Investment & Acquisitions

NovaXS & 43 more

Similar Companies

Boston Scientific & 1565 more

Exit Details

Acquired by Warburg Pincus (Oct 02, 2023)

View Baxter's full profile

Baxter is associated with 16 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BAXTER HEALTHCARE [THAILAND] COMPANY LIMITED CIN: 0105537131713 , Thailand, Active	Nov 03, 1994	$110M (As on Dec 31, 2022)	-
Baxter Healthcare S.a. CIN: 660678126 , United States, Active	Dec 31, 1999	-	2104 (As on Dec 31, 2023)	-
BAXTER TECHNOLOGY GROUP, INC. CIN: 273421356 , United States, Active	Dec 31, 1999	-	15 (As on Dec 31, 2022)	-
BAXTER Latvia CIN: 40103312373 , Latvia, Active	Aug 09, 2010	$123K (As on Dec 31, 2024)	1 (As on Dec 31, 2018)	-
BAXTER INTERNATIONAL INC CIN: 10456 , United States, Active	Mar 20, 1994	$10.6B (As on Dec 31, 2024)	-	-
BAXTER, INC. CIN: 43026692 , United States, Active	Dec 31, 1999	-	13 (As on Dec 31, 2024)	-
BAXTER INNOVATIONS AND BUSINESS SOLUTIONS PRIVATE LIMITED CIN: U74999KA2017PTC109068 , India, Active	Dec 29, 2017	$72.1M (As on Mar 31, 2025)	1124 (As on Oct 31, 2024)
LARGO company s.r.o. CIN: 26364395 , Czech Republic, Active	Dec 03, 2003	-	-
BAXTER INDIA PRIVATE LIMITED CIN: U33112HR1996PTC038528 , India, Active	Jun 11, 1996	$57.5M (As on Mar 31, 2025)	81 (As on Mar 01, 2017)
CHARLES BAXTER LTD CIN: 12881910 , United Kingdom, Active	Sep 14, 2020	$2.21K (As on Sep 30, 2024)	1 (As on Sep 30, 2025)
BAX Trust s.r.o. CIN: 03541738 , Czech Republic, Active	Nov 04, 2014	-	-
Baxter International CIN: 360781620 , Belgium, Active		-	23259 (As on Dec 31, 2021)	-
BAXTERS REFRIGERANTS LTD CIN: 13236527 , United Kingdom, Active	Feb 28, 2021	$12.6K (As on Dec 31, 2024)	-
Baxter International Inc. CIN: 360781620 , United States, Active	Dec 31, 1999	-	15900 (As on Dec 31, 2024)	-
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED CIN: U24230GJ2005PTC046211 , India, Active	Jun 08, 2005	$79.4M (As on Mar 31, 2025)	1151 (As on Oct 31, 2024)
Vantive s.r.o. CIN: 19678941 , Czech Republic, Active	Aug 31, 2023	-	-

Baxter got acquired by Warburg Pincus and Advent International on Oct 02, 2023.

Click here to take a look at Baxter's acquisition in detail

Baxter has raised funding over 6 rounds. Its first funding round was on 2012. Its latest funding round was a Grant (prize money) round on May 19, 2022 for $*****. 1 investor participated in its latest round. Baxter has 9 institutional investors.

Here is the list of recent funding rounds of Baxter:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 19, 2022	5661166	Grant (prize money)	3725166	1706698	6135471	8580318
Jun 18, 2021	2907831	Grant (prize money)	9923610	7808012	2339952	Bmbf
2019	8778	Grant (prize money)	9993	8985	3732	Bmbf

Access funding benchmarks and valuations. Sign up today!

View details of Baxter's funding rounds and investors

Baxter's employee count trend

Baxter has 39,385 employees as of Jan 26. Here is Baxter's employee count trend over the years:

Uncover Baxter's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Baxter include Boston Scientific, Medtronic and Fujifilm. Here is the list of Top 10 competitors of Baxter, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Boston Scientific 1979, Marlborough (United States), Public	Wide range of medical devices	-	JANA Partners, Barclays & 8 others	81/100
2nd	Medtronic 1949, Minneapolis (United States), Public	Developer of medical equipment for chronic diseases	-	Greyrock Investments, Saints Capital & 23 others	79/100
3rd	Fujifilm 1934, Germany, Acquired	Developer of healthcare, electronics, and imaging solutions for various applications	-	ENEOS Group, BOM & 3 others	77/100
4th	Trivitron 1997, Chennai (India), Series C	R&D company manufacturing medical devices for multiple therapeutic areas	$109M	Fidelity Investments, Eight Roads Ventures ... & 19 others	67/100
5th	HOYA 1941, Shinjuku (Japan), Public	Developer of a wide range of medical devices	-	-	66/100
6th	SAGE Therapeutics 1971, Boston (United States), Acquired	Developer of drug candidates for the treatment of rare CNS disorders	$106M	EcoR1, Orbimed & 10 others	66/100
7th	Stryker 1941, Kalamazoo (United States), Acquired	Manufacturer of 3D-printed orthopedic products	-	Castle Investment Management, Tekla Capital Management ... & 3 others	66/100
8th	Teleflex Medical 1943, Wayne (United States), Public	Provider of medical devices for emergency medicine and various health conditions	-	TATRC, Europa & 1 others	65/100
9th	CONMED 1987, Utica (United States), Public	R&D company focused on manufacturing of surgical instruments for multiple therapeutic areas	-	Barclays, Hudson River Capital Partners & 2 others	64/100
10th	Biorad Medisys 2007, Pune (India), Series A	Manufacturer of medical devices for orthopaedic, neurovascular, and endovascular procedures	$53.4M	InvAscent, BioMediCon & 5 others	64/100
11th	Baxter 1931, Deerfield (United States), Acquired	Provides biosciences, medication delivery and renal products	-	Triodos Investment Management, Tekla Capital Management ... & 7 others	68/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Baxter's competitors? Click here to see the top ones

Baxter has made 24 investments in companies including NovaXS and Medically Home. Baxter has also acquired 20 companies including Hillrom and toSense.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 31, 2022	Investments	NovaXS	2021	Berkeley (United States)
Jan 07, 2022	Investments	Medically Home	2017	Boston (United States)
Sep 02, 2021	Acquisition	Hillrom	1915	Chicago (United States)